EP.07C.10 Real-World Outcomes of Patients Treated with Neoadjuvant Immunotherapy for Resectable Non-Small Cell Lung Cancer
Ermer T, Kim S, Goldberg S, Zolfaghari E, Blasberg J, Boffa D, Herbst R, Politi K, Schalper K, Dacic S, Woodard G. EP.07C.10 Real-World Outcomes of Patients Treated with Neoadjuvant Immunotherapy for Resectable Non-Small Cell Lung Cancer. Journal Of Thoracic Oncology 2024, 19: s543-s544. DOI: 10.1016/j.jtho.2024.09.1007.Peer-Reviewed Original ResearchWhat is the role of perioperative immunotherapy and chemotherapy in stage III resectable non-small cell lung cancer?
Zolfaghari E, Antonoff M. What is the role of perioperative immunotherapy and chemotherapy in stage III resectable non-small cell lung cancer? AME Clinical Trials Review 2024, 2: 73-73. DOI: 10.21037/actr-24-88.Peer-Reviewed Original Research